Incorporeal Pharma Private Limited - Company Profile

It is a trading private limited company based in Sangli, Maharashtra, India, established in 2021.
2021 Sangli, Maharashtra, India Active
Last Updated:
Access Report
About Incorporeal Pharma Private Limited

Incorporeal Pharma Private Limited, a active private limited company, was established on 22 October 2021 in Sangli, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909PN2021PTC205424. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sharad Aannaso Patil (Additional Director), Sachin Bhagwant Gondhale (Director), Aniket Sangameshwarkar (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at G3 ,Pranam Arcade, Kacchi Bhavan,Sangli, Sangli, Maharashtra, 416416.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909PN2021PTC205424

  • Registration Number

    205424

  • Incorporation Date

    22 October 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Incorporeal Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Incorporeal Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Incorporeal Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sharad Aannaso Patil Additional Director 21 Aug 2023 Current
Sachin Bhagwant Gondhale Director 22 Oct 2021 Current
Aniket Sangameshwarkar Director 22 Oct 2021 Current
Amit Ashok Shetti Director 22 Oct 2021 Current
Jayshri Rajshekhar Hiremath Additional Director 27 Nov 2022 Current
Dineshkumar Haribhau Dandekar Additional Director 06 Dec 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Incorporeal Pharma.

Enhance accessibility to Incorporeal Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Incorporeal Pharma revenue growth over time
Incorporeal Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Incorporeal Pharma?

Unlock access to Incorporeal Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Incorporeal Pharma?

Incorporeal Pharma has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Incorporeal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incorporeal Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Incorporeal Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Incorporeal Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Incorporeal Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.

  • Director Appointment

    Progress on Sharad Aannaso Patil was appointed as a Additional Director was appointed as a Additional Director on 21 Aug 2023 & has been associated with this company since 2 years 5 months . was documented.

  • Director Appointment

    Dineshkumar Haribhau Dandekar was appointed as a Additional Director was appointed as a Additional Director on 06 Dec 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Jayshri Rajshekhar Hiremath was appointed as a Additional Director was appointed as a Additional Director on 27 Nov 2022 & has been associated with this company since 3 years 2 months . was documented.

  • Director Appointment

    The activity Sachin Bhagwant Gondhale was appointed as a Director was appointed as a Director on 22 Oct 2021 & has been associated with this company since 4 years 3 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Incorporeal Pharma Private Limited?

The CIN of Incorporeal Pharma Private Limited is U51909PN2021PTC205424.

Where is Incorporeal Pharma Private Limited headquartered?

Incorporeal Pharma Private Limited is headquartered at G3 ,Pranam Arcade, Kacchi Bhavan,Sangli, Sangli, Maharashtra, 416416.

When was Incorporeal Pharma Private Limited incorporated?

Incorporeal Pharma Private Limited was incorporated on 22 October 2021.

Who are the current directors of Incorporeal Pharma Private Limited?

The current directors of Incorporeal Pharma Private Limited are

What is the primary industry of Incorporeal Pharma Private Limited?

The primary industry of Incorporeal Pharma Private Limited is Trading.

Is Incorporeal Pharma Private Limited a listed company?

Incorporeal Pharma Private Limited is unlisted.

What is the capital structure of Incorporeal Pharma Private Limited?

The authorized capital of Incorporeal Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available